Swiss Life Asset Management’s Celanese CE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $334K | Buy |
7,252
+687
| +10% | +$39.8K | ﹤0.01% | 1198 |
|
|
2026
Q1 | $432K | Buy |
6,565
+1,570
| +31% | +$82K | ﹤0.01% | 932 |
|
|
2025
Q4 | $211K | Buy |
+4,995
| New | +$204K | ﹤0.01% | 1247 |
|
|
2025
Q3 | – | Sell |
-6,521
| Closed | -$361K | – | 1195 |
|
|
2025
Q2 | $361K | Buy |
6,521
+1,032
| +19% | +$51.4K | ﹤0.01% | 694 |
|
|
2025
Q1 | $312K | Sell |
5,489
-5,562
| -50% | -$347K | ﹤0.01% | 672 |
|
|
2024
Q4 | $764K | Buy |
11,051
+6,733
| +156% | +$647K | 0.01% | 624 |
|
|
2024
Q3 | $586K | Sell |
4,318
-2,162
| -33% | -$284K | 0.01% | 505 |
|
|
2024
Q2 | $874K | Buy |
6,480
+3,729
| +136% | +$570K | 0.01% | 451 |
|
|
2024
Q1 | $473K | Sell |
2,751
-875
| -24% | -$133K | 0.01% | 443 |
|
|
2023
Q4 | $565K | Sell |
3,626
-15,812
| -81% | -$2.06M | 0.01% | 546 |
|
|
2023
Q3 | $2.44M | Sell |
19,438
-25,598
| -57% | -$3.15M | 0.04% | 419 |
|
|
2023
Q2 | $5.21M | Hold |
45,036
| – | – | 0.08% | 297 |
|
|
2023
Q1 | $4.9M | Buy |
45,036
+34,163
| +314% | +$3.94M | 0.07% | 312 |
|
|
2022
Q4 | $1.11M | Sell |
10,873
-6,731
| -38% | -$668K | 0.02% | 485 |
|
|
2022
Q3 | $1.59M | Buy |
17,604
+3,460
| +24% | +$380K | 0.03% | 455 |
|
|
2022
Q2 | $1.66M | Sell |
14,144
-5,146
| -27% | -$739K | 0.03% | 446 |
|
|
2022
Q1 | $2.76M | Sell |
19,290
-17,908
| -48% | -$2.73M | 0.04% | 388 |
|
|
2021
Q4 | $6.25M | Buy |
37,198
+19,453
| +110% | +$3.17M | 0.08% | 274 |
|
|
2021
Q3 | $2.67M | Sell |
17,745
-39,381
| -69% | -$6.07M | 0.04% | 386 |
|
|
2021
Q2 | $11.3M | Buy |
57,126
+28,703
| +101% | +$4.56M | 0.11% | 173 |
|
|
2021
Q1 | $4.26M | Buy |
28,423
+22,061
| +347% | +$3.03M | 0.06% | 336 |
|
|
2020
Q4 | $826K | Sell |
6,362
-28,783
| -82% | -$3.58M | 0.01% | 451 |
|
|
2020
Q3 | $3.78M | Buy |
35,145
+7,733
| +28% | +$772K | 0.06% | 230 |
|
|
2020
Q2 | $2.37M | Buy |
27,412
+24,280
| +775% | +$2.02M | 0.04% | 306 |
|
|
2020
Q1 | $230K | Sell |
3,132
-20,780
| -87% | -$2.06M | ﹤0.01% | 475 |
|
|
2019
Q4 | $2.94M | Buy |
23,912
+17,618
| +280% | +$2.17M | 0.06% | 271 |
|
|
2019
Q3 | $770K | Sell |
6,294
-58,136
| -90% | -$6.55M | 0.01% | 411 |
|
|
2019
Q2 | $6.94M | Sell |
64,430
-18,101
| -22% | -$1.87M | 0.08% | 156 |
|
|
2019
Q1 | $8.14M | Buy |
+82,531
| New | +$8.12M | 0.1% | 140 |
|
|
2018
Q4 | – | Sell |
-3,361
| Closed | -$383K | – | 233 |
|
|
2018
Q3 | $383K | Sell |
3,361
-12,168
| -78% | -$1.4M | 0.01% | 480 |
|
|
2018
Q2 | $1.73M | Buy |
+15,529
| New | +$1.71M | 0.03% | 324 |
|
|
2017
Q2 | – | Sell |
-9,062
| Closed | -$814K | – | 458 |
|
|
2017
Q1 | $814K | Buy |
+9,062
| New | +$791K | 0.02% | 339 |
|
Other funds holding CE
Swiss Life Asset Management's CE Position: Q2 2026 in Review
Swiss Life Asset Management increased its Celanese (CE) stake by 10% in Q2 2026, buying an estimated $39.8K and bringing the position to 7,252 shares worth $334K. The position accounts for ﹤0.01% of the portfolio, ranked #1198.
Swiss Life Asset Management first reported a position in CE in Q1 2017 and has held it in 32 quarters since. The position peaked at $11.3M in Q2 2021. 283 funds tracked by Wall St. Rank hold CE as of Q2 2026.
- Swiss Life Asset Management held 7,252 shares of Celanese worth $334K as of Q2 2026.
- Swiss Life Asset Management bought 687 Celanese shares in Q2 2026, an estimated $39.8K.
- Celanese made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1198 holding.
- Swiss Life Asset Management first reported a position in Celanese in Q1 2017 and has held it in 32 quarters since.
- Swiss Life Asset Management's Celanese position peaked at $11.3M in Q2 2021.
- 283 funds tracked by Wall St. Rank held Celanese as of Q2 2026.
Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.